Laurus Labs Ltd
NSE:LAURUSLABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Laurus Labs Ltd
NSE:LAURUSLABS
|
IN |
|
K2FLY Ltd
ASX:K2F
|
AU |
|
Penumbra Inc
NYSE:PEN
|
US |
|
F
|
First Gen Corp
XPHS:FGEN
|
PH |
|
UMB Financial Corp
NASDAQ:UMBF
|
US |
|
Concord Medical Services Holdings Ltd
NYSE:CCM
|
CN |
|
R
|
Renta 4 Banco SA
F:4RE
|
ES |
|
T
|
Thrace Plastics Holding and Commercial SA
ATHEX:PLAT
|
GR |
|
H
|
HIVE Blockchain Technologies Ltd
F:HBF
|
CA |
Wall Street
Price Targets
LAURUSLABS Price Targets Summary
Laurus Labs Ltd
According to Wall Street analysts, the average 1-year price target for
LAURUSLABS
is 1 018.35 INR
with a low forecast of 686.8 INR and a high forecast of 1 344 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LAURUSLABS's stock price target?
Price Target
1 018.35
INR
According to Wall Street analysts, the average 1-year price target for
LAURUSLABS
is 1 018.35 INR
with a low forecast of 686.8 INR and a high forecast of 1 344 INR.
What is Laurus Labs Ltd's Revenue forecast?
Projected CAGR
18%
For the last 10 years the
compound annual growth rate for
Laurus Labs Ltd's revenue is
15%.
The projected
CAGR
for the next 3 years is
18%.
What is Laurus Labs Ltd's Operating Income forecast?
Projected CAGR
44%
For the last 10 years the
compound annual growth rate for
Laurus Labs Ltd's operating income is
16%.
The projected
CAGR
for the next 3 years is
44%.
What is Laurus Labs Ltd's Net Income forecast?
Projected CAGR
54%
For the last 10 years the
compound annual growth rate for
Laurus Labs Ltd's net income is
18%.
The projected
CAGR
for the next 3 years is
54%.
